NMS-P118
Product Specifications
UNSPSC Description
NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy.
Target Antigen
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NMS-P118.html
Purity
99.78
Solubility
DMSO : 16 mg/mL (ultrasonic;warming)
Smiles
FC(CC1)(F)CCC1N(CC2)CCC2N(C3=O)CC4=C3C(C(N)=O)=CC(F)=C4
Molecular Weight
395.42
References & Citations
[1]Papeo G, et al. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. J Med Chem. 2015 Sep 10;58(17):6875-98.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-18954/NMS-P118-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-18954/NMS-P118-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1262417-51-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1141483-01 0.02 mg (E-Coli)
Recombinant Rickettsia rickettsii Putative phosphotransferase RrIowa_0001 (RrIowa_0001)
Ask
View Details MBS1141483-02 0.02 mg (Yeast)
Recombinant Rickettsia rickettsii Putative phosphotransferase RrIowa_0001 (RrIowa_0001)
Ask
View Details MBS1141483-03 0.1 mg (E-Coli)
Recombinant Rickettsia rickettsii Putative phosphotransferase RrIowa_0001 (RrIowa_0001)
Ask
View Details